Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Homo sapiens | pyruvate kinase, muscle | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | pyruvate kinase | pyruvate kinase, muscle | 605 aa | 521 aa | 34.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | pyruvate kinase | 0.004 | 0.0234 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.007 | 0.1341 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.007 | 0.1341 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.0152 | 0.5671 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.007 | 0.1341 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.004 | 0.0234 | 0.019 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.004 | 0.0234 | 0.0165 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.105 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.004 | 0.0234 | 0.0165 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.007 | 0.1341 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0234 | 0.0165 |
Plasmodium falciparum | pyruvate kinase | 0.004 | 0.0234 | 0.019 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.004 | 0.0234 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0028 | 0.0116 | 0.0047 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0448 | 0.4177 | 0.4136 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.004 | 0.0234 | 0.0165 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.004 | 0.0234 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.007 | 0.2987 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0116 | 0.0047 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.105 | 1 | 1 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.004 | 0.0234 | 0.0165 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.105 | 1 | 1 |
Mycobacterium ulcerans | pyruvate kinase | 0.004 | 0.0234 | 1 |
Plasmodium vivax | pyruvate kinase, putative | 0.004 | 0.0234 | 0.019 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.105 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Echinococcus multilocularis | pyruvate kinase | 0.004 | 0.0234 | 1 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.105 | 1 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.007 | 0.0026 |
Loa Loa (eye worm) | pyruvate kinase | 0.004 | 0.0234 | 0.0165 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.105 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.007 | 0.1341 |
Schistosoma mansoni | pyruvate kinase | 0.004 | 0.0234 | 1 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0028 | 0.0116 | 0.0047 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.007 | 0.2987 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.004 | 0.0234 | 0.5 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.004 | 0.0234 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.007 | 0.1341 |
Schistosoma mansoni | pyruvate kinase | 0.004 | 0.0234 | 1 |
Trypanosoma brucei | pyruvate kinase 1 | 0.004 | 0.0234 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.007 | 0.2987 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.007 | 0.2987 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.004 | 0.0234 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.105 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.004 | 0.0234 | 0.0165 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.105 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.004 | 0.0234 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.105 | 1 | 1 |
Giardia lamblia | Pyruvate kinase | 0.004 | 0.0234 | 0.019 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.004 | 0.0234 | 1 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.004 | 0.0234 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.105 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.004 | 0.0234 | 0.0165 |
Loa Loa (eye worm) | pyruvate kinase | 0.004 | 0.0234 | 0.0165 |
Chlamydia trachomatis | pyruvate kinase | 0.004 | 0.0234 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.007 | 0.1341 |
Echinococcus granulosus | pyruvate kinase | 0.004 | 0.0234 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.004 | 0.0234 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.007 | 0.1341 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.004 | 0.0234 | 0.0165 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.007 | 0.2987 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0448 | 0.4177 | 0.4136 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.007 | 0.2987 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.007 | 0.1341 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 79.37 um | PUBCHEM_BIOASSAY: Dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma). (Class of assay: confirmatory) [Related pubchem assays: 631, 731, 1032, 1300 ] | ChEMBL. | No reference |
EC50 (functional) | > 79.37 um | PUBCHEM_BIOASSAY: Dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma). (Class of assay: confirmatory) [Related pubchem assays: 1032, 631, 731 ] | ChEMBL. | No reference |
EC50 (functional) | > 79.37 um | PUBCHEM_BIOASSAY: Dose response biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma). (Class of assay: confirmatory) [Related pubchem assays: 1032, 631, 731 ] | ChEMBL. | No reference |
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 37.6505 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.